GPR172A anticorps (AA 217-276) (FITC)

N° du produit ABIN7170277

Cet anticorps anti-GPR172A est un anticorps Lapin Polyclonal détectant GPR172A dans . Adapté pour Humain.

Aperçu rapide pour GPR172A anticorps (AA 217-276) (FITC) (ABIN7170277)

Antigène: GPR172A (G Protein-Coupled Receptor 172A (GPR172A))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GPR172A est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Détail du produit anti-GPR172A anticorps (FITC)

Épitope: AA 217-276

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Solute carrier family 52, riboflavin transporter, member 2 protein (217-276AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur GPR172A

Antigène: GPR172A (G Protein-Coupled Receptor 172A (GPR172A))

Autre désignation: SLC52A2

Sujet:

Background: Riboflavin transporter. Riboflavin transport is Na(+)-independent but moderately pH -sensitive. Activity is strongly inhibited by riboflavin analogs, such as lumiflavin. Weakly inhibited by flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN). In case of infection by retroviruses, acts as a cell receptor to retroviral envelopes similar to the porcine endogenous retrovirus (PERV-A).

Aliases: SLC52A2 antibody, GPR172A antibody, PAR1 antibody, RFT3 antibody, Solute carrier family 52 antibody, riboflavin transporter antibody, member 2 antibody, Porcine endogenous retrovirus A receptor 1 antibody, PERV-A receptor 1 antibody, Protein GPR172A antibody, Riboflavin transporter 3 antibody, hRFT3 antibody

UniProt: Q9HAB3

Pathways: Nuclear Receptor Transcription Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response